why choose us

First received: March 23, 2023

Clinical Trial: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cerebral Adrenoleukodystrophy (cALD)

Study Type: INTERVENTIONAL


Official Title: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Brief Summary: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.

Read more